Damian Daniel Zakroczemski, RPAC

Damian Zakroczemski practices at Primary Care of Western New York LLP in Buffalo, New York.

Damian Zakroczemski's NPI, 1811129315, was assigned on August 17, 2009. Damian Zakroczemski holds New York license 013286.

Damian Zakroczemski's primary practice is Primary Care of Western New York LLP, at 30 N Union Rd, Buffalo, NY 14221 in Erie County. The practice phone is (716) 839-8000.

Damian Zakroczemski's primary practice is Primary Care of Western New York LLP in Buffalo, New York. The medical group on file is Primary Care of Western New York. Dmand AI also links Damian Zakroczemski to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Damian Zakroczemski practices. Vendor and product names are available with a free account.

Physician assistant is Damian Zakroczemski's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Damian Zakroczemski is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Damian Zakroczemski is licensed in New York.

Dmand AI lists acute sinusitis, acute skin infection, arthritis, asthma, bronchitis, chest wall injury, chronic obstructive pulmonary disease (COPD) and enlarged prostate among the conditions Damian Zakroczemski treats.

CMS data shows 33 Medicare services from Damian Zakroczemski across 2 procedure codes in 2024, all of them office visits, for 33 Medicare patients. Medicare paid $1,727 for them. Every service was in an office.

CMS counts 33 Medicare patients who saw Damian Zakroczemski in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Damian Zakroczemski's median patient age at 70, with 29% women.

In 2024, Damian Zakroczemski wrote 1,893 Medicare Part D claims for 334 patients. 89% of them were for generic drugs. CMS names the drug for 1,493 of them, across 44 drugs with 11 or more claims each, at $127,067 in total drug cost.